Literature DB >> 26661150

Long-term dynamics of somatosensory activity in a stroke model of distal middle cerebral artery oclussion.

Juan A Barios1, Liudmila Pisarchyk1, Laura Fernandez-Garcia1, Luis C Barrio2, Milagros Ramos3, Ricardo Martinez-Murillo4, Daniel Gonzalez-Nieto5.   

Abstract

A constant challenge in experimental stroke is the use of appropriate tests to identify signs of recovery and adverse effects linked to a particular therapy. In this study, we used a long-term longitudinal approach to examine the functional brain changes associated with cortical infarction in a mouse model induced by permanent ligation of the middle cerebral artery (MCA). Sensorimotor function and somatosensory cortical activity were evaluated with fault-foot and forelimb asymmetry tests in combination with somatosensory evoked potentials. The stroke mice exhibited both long-term deficits in the functional tests and impaired responses in the infarcted and intact hemispheres after contralateral and ipsilateral forepaw stimulation. In the infarcted hemisphere, reductions in the amplitudes of evoked responses were detected after contralateral and ipsilateral stimulation. In the intact hemisphere, and similar to cortical stroke patients, a gradual hyperexcitability was observed after contralateral stimulation but no parallel evidence of a response was detected after ipsilateral stimulation. Our results suggest the existence of profound and persistent changes in the somatosensory cortex in this specific mouse cortical stroke model. The study of evoked potentials constitutes a feasible and excellent tool for evaluating the fitness of the somatosensory cortex in relation to functional recovery after preclinical therapeutic intervention.
© The Author(s) 2015.

Entities:  

Keywords:  Behavior; somatosensory evoked potentials; stroke neuroprotection and repair

Mesh:

Year:  2015        PMID: 26661150      PMCID: PMC4794092          DOI: 10.1177/0271678X15606139

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  48 in total

1.  Evaluation of 2,3,5-triphenyltetrazolium chloride staining to delineate rat brain infarcts.

Authors:  K Isayama; L H Pitts; M C Nishimura
Journal:  Stroke       Date:  1991-11       Impact factor: 7.914

Review 2.  Thalamocortical synapses.

Authors:  M A Castro-Alamancos; B W Connors
Journal:  Prog Neurobiol       Date:  1997-04       Impact factor: 11.685

3.  The glycine antagonist GV150526 protects somatosensory evoked potentials and reduces the infarct area in the MCAo model of focal ischemia in the rat.

Authors:  F Bordi; C Pietra; L Ziviani; A Reggiani
Journal:  Exp Neurol       Date:  1997-06       Impact factor: 5.330

4.  Environment influences functional outcome of cerebral infarction in rats.

Authors:  A L Ohlsson; B B Johansson
Journal:  Stroke       Date:  1995-04       Impact factor: 7.914

5.  Ketamine effects on somatosensory cortical single neurons and on behavior in rats.

Authors:  I M Patel; J K Chapin
Journal:  Anesth Analg       Date:  1990-06       Impact factor: 5.108

6.  Human cortical potentials evoked by stimulation of the median nerve. II. Cytoarchitectonic areas generating long-latency activity.

Authors:  T Allison; G McCarthy; C C Wood; P D Williamson; D D Spencer
Journal:  J Neurophysiol       Date:  1989-09       Impact factor: 2.714

7.  Arm and leg paresis as outcome predictors in stroke rehabilitation.

Authors:  T S Olsen
Journal:  Stroke       Date:  1990-02       Impact factor: 7.914

8.  Somatosensory evoked potentials in rat cerebral cortex before and after middle cerebral artery occlusion.

Authors:  K Sakatani; H Iizuka; W Young
Journal:  Stroke       Date:  1990-01       Impact factor: 7.914

9.  Focal brain ischemia in the rat: methods for reproducible neocortical infarction using tandem occlusion of the distal middle cerebral and ipsilateral common carotid arteries.

Authors:  S Brint; M Jacewicz; M Kiessling; J Tanabe; W Pulsinelli
Journal:  J Cereb Blood Flow Metab       Date:  1988-08       Impact factor: 6.200

10.  Neocortical neural sprouting, synaptogenesis, and behavioral recovery after neocortical infarction in rats.

Authors:  R P Stroemer; T A Kent; C E Hulsebosch
Journal:  Stroke       Date:  1995-11       Impact factor: 7.914

View more
  5 in total

1.  Motor deficit in the mouse ferric chloride-induced distal middle cerebral artery occlusion model of stroke.

Authors:  Nausheen Syeara; Faisal F Alamri; Srinidhi Jayaraman; Peia Lee; Serob T Karamyan; Thiruma V Arumugam; Vardan T Karamyan
Journal:  Behav Brain Res       Date:  2019-12-05       Impact factor: 3.332

2.  Postischemic Neuroprotection of Aminoethoxydiphenyl Borate Associates Shortening of Peri-Infarct Depolarizations.

Authors:  Rocío Fernández-Serra; Emma Martínez-Alonso; Alberto Alcázar; Mourad Chioua; José Marco-Contelles; Ricardo Martínez-Murillo; Milagros Ramos; Gustavo V Guinea; Daniel González-Nieto
Journal:  Int J Mol Sci       Date:  2022-07-04       Impact factor: 6.208

3.  Cortical Reshaping and Functional Recovery Induced by Silk Fibroin Hydrogels-Encapsulated Stem Cells Implanted in Stroke Animals.

Authors:  Laura Fernández-García; José Pérez-Rigueiro; Ricardo Martinez-Murillo; Fivos Panetsos; Milagros Ramos; Gustavo V Guinea; Daniel González-Nieto
Journal:  Front Cell Neurosci       Date:  2018-09-06       Impact factor: 6.147

4.  Cortical tissue loss and major structural reorganization as result of distal middle cerebral artery occlusion in the chronic phase of nude mice.

Authors:  Anuka Minassian; Marina Dobrivojevic Radmilovic; Stefanie Vogel; Michael Diedenhofen; Melanie Nelles; Maren Stoeber; Dirk Wiedermann; Mathias Hoehn
Journal:  Sci Rep       Date:  2019-05-02       Impact factor: 4.379

Review 5.  Biomaterials to Neuroprotect the Stroke Brain: A Large Opportunity for Narrow Time Windows.

Authors:  Daniel González-Nieto; Rocío Fernández-Serra; José Pérez-Rigueiro; Fivos Panetsos; Ricardo Martinez-Murillo; Gustavo V Guinea
Journal:  Cells       Date:  2020-04-26       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.